Navigation Links
Oncology Group's Pharmaceutical Services Agreement Enhances Efficiency of Drug Management Program
Date:6/29/2009

THE WOODLANDS, Texas, June 29 /PRNewswire/ -- The physicians of Hematology-Oncology Associates, P.C in Albuquerque, N.M., an eight provider community based specialty practice caring for adults with cancers and blood disorders, today announced they have entered into an agreement with Oncology Pharmaceutical Services (OPS) to secure its oncology drug purchasing, distribution services, and the support of an oncology-trained consultant pharmacist.

By working with OPS, a service of US Oncology, Inc., Hematology-Oncology Associates has access to a range of services focused on enhancing the performance of the practice. The services are customized to the specific needs of community-based practices and include drug management services, such as admixture training, inventory management, enhanced charge capture, regimen analysis, and admixture and clinical staff training and education.

"This type of support allows us to practice more efficiently and will help us continue to provide the excellent service and quality of care that the community has come to expect from us," said Dr. Victor Vigil, lead oncologist at Hematology-Oncology Associates.

State-of-the-art drug distribution services and network drug contracting are vital parts of the services provided by OPS to benefit the Hematology-Oncology Associates practice. As a complement to these OPS services, the consultant pharmacist is a resource who focuses on providing ongoing economic value and process improvement support to Hematology-Oncology Associates.

The relationship brings together the expertise of seven oncologists, a clinical nurse specialist, and many support staff with the knowledge of an oncology pharmacist team that share a vision of optimizing practice performance in the community setting.

About Hematology Oncology Associates, P.C.

For over 30 years, the physicians and staff at Hematology Oncology Associates of New Mexico have been providing comprehensive care for adults with cancer and blood disorders. With state-of-the-art treatment technologies, cutting-edge clinical trials research, and access to a wide array of services, the practice is devoted to providing the best possible care to its patients.

Co-founder Dr. Paul Duncan, and his colleagues Dr. Victor Vigil, Dr. Lorraine Sanchez, Dr. Malcolm Purdy, Dr. James Lin, Dr. Lovie Bey and Debra Winkeljohn, CNS, are committed to providing the people of New Mexico with the highest standard of care available. In addition, two of the group's physicians are focused on genetic screening and counseling for patients and family members with hereditary cancers. For more information, visit the company's Web site, www.hoanm.com.

About Oncology Pharmaceutical Services

Oncology Pharmaceutical Services (OPS), a service of US Oncology, Inc., includes powerful network drug contracting, state-of-the art drug distribution, and the valuable support of oncology-trained consultant pharmacists. In addition, OPS offers a variety of innovative tools and resources specially designed for the complexity of cancer care, focusing on providing economic value, clinical insight, and process improvement.

About US Oncology

US Oncology, Inc., headquartered in the Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
2. US Oncology Offers Electronic Health Records Informative Webinar
3. Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care Nationwide
4. US Oncology, Inc. Announces Issuance of $775 Million of Debt Securities
5. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
6. Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award
7. US Oncology Launches Oncology-Specific EHR to the Open Market
8. Aptium Oncology Names New Chief Operating Officer
9. New Debt Securities of US Oncology, Inc.
10. Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer
11. US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... CA (PRWEB) , ... September 22, 2017 , ... ... to help you brush more effectively even on the go. Their electric toothbrushes ... gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke technology ...
(Date:9/22/2017)... ... September 22, 2017 , ... Global ... diseases through research, education and awareness, today announced the appointment of Timothy J. ... microbiologist, Dr. Sellati has more than 20 years of research experience with Lyme ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction Treatment Association ... professionals in the addiction treatment industry entitled: Special Investigations Unit (SIU) – ... and state and federal governments are increasingly scrutinizing the addiction treatment industry for ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... exercise more try taking a more holistic approach and use natural alternatives for ... essential oil collection is certified USDA guaranteeing that, the new line of essential ...
(Date:9/21/2017)... ... September 21, 2017 , ... A ... addiction recovery at a time when Virginia faces an opioid epidemic. ... a staggering increase of 38 percent from 2015, underscoring the need for additional ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017  Medical professionals are expected to ... treating their patients. Medical simulations offer clinicians ... patients. Simulation provides a safe method for ... procedures, refine techniques and build confidence, without ... technology, such as augmented reality, will now ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
(Date:9/5/2017)... Sept. 5, 2017 Sapheneia and Scannerside received ... Scannerside DoseCheck is a third-party Vendor neutral CT product ... and allows compliance with current MITA standards. ... 29 DoseCheck solution is specifically designed to provide CT ... potential radiation doses over a predefined threshold. Scannerside Dose ...
Breaking Medicine Technology: